Advances in hemangioma evaluation and treatment.
Argenta
L C
LC
Department of Plastic and Reconstructive Surgery, Wake Forest University Baptist Medical Center, Winston-Salem, North Carolina 27157, USA. LARGENTA@wsubmc.edu
David
L R
LR
Sanger
C
C
Park
C
C
D000305:Adrenal Cortex Hormones / Q000008:administration & dosage / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000032:analysis; D006391:Hemangioma / Q000145:classification / Q000175:diagnosis* / Q000628:therapy; D006801:Humans; D015552:Injections, Intralesional; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use; D017075:Laser Coagulation; D011994:Recombinant Proteins; D018570:Risk Assessment; D012878:Skin Neoplasms / Q000175:diagnosis / Q000628:therapy; D012983:Soft Tissue Neoplasms / Q000175:diagnosis / Q000628:therapy
D000305:Adrenal Cortex Hormones; D000893:Anti-Inflammatory Agents; D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins